Genetic Technologies Limited

GTG

AU000000GTG7

Healthcare Facilities & Services

Market Closed - Australian S.E. Other stock markets 06:01:01 01/07/2024 BST			5-day change	1st Jan Change
0.081 ^AUD	+8.00%		-2.41%	-40.00%

06-28	Genetic Technologies CFO Steps Down	MT
06-28	Genetic Technologies Limited Announces Resignation of Kathryn Andrews as Company Secretary	CI

Genetic Technologies Limited Announces Resignation of Kathryn Andrews as CFO

June 28, 2024 at 08:01 am

Genetic Technologies Limited announced that Kathryn Andrews has provided her notice of resignation as Chief Financial Officer of the Company. The Company will commence a search for a new CFO.

Latest news about Genetic Technologies Limited

Genetic Technologies CFO Steps Down	06-28	MT
Genetic Technologies Limited Announces Resignation of Kathryn Andrews as Company Secretary	06-28	CI
Genetic Technologies Limited Announces Resignation of Kathryn Andrews as CFO	06-28	CI
Transcript : Genetic Technologies Limited - Special Call	06-27
Genetic Technologies Limited Share the Power of the geneType Test in Identifying Risk and Improving the Health of Populations Worldwide	06-25	CI
Genetic Technologies Starts Testing Operations in the US	06-18	MT
Genetic Technologies Expands Operational Capacity in North America	06-18	CI
Genetic Technologies Begins GeneType Products Testing in the US	06-18	MT
Genetic Technologies Signs Multi-Risk Test Distribution Deal With Stayhealthy	06-05	MT
Genetic Technologies, Stayhealthy Enter Distribution Agreement for Multi-Risk Test in North America	06-05	MT
Genetic Technologies Limited and Stayhealthy, Inc. Announces Major Distribution Agreement for Revolutionary Multi-Risk Test	06-05	CI
GTG Launches Revolutionary geneType Test Covering 100% Risk of Breast and Ovarian Cancer	05-29	CI
Accelerating Domestic Inflation Drags Australian Shares to More than Three-Week Low	05-29	MT
Genetic Technologies Releases Risk Assessment Test for Breast, Ovarian Cancer; Shares Jump 14%	05-29	MT
Genetic Technologies Limited Announces Execution of Strategic Joint Sales & Marketing Agreement with Wellworks for You Inc	05-06	CI
Genetic Technologies Signs Sales, Marketing Deal with Wellworks for You	05-06	MT
Genetic Technologies Raising $2 Million via ADS Offering	04-19	MT
Top Midday Decliners	04-18	MT
Genetic Technologies Agrees to $2 Million Equity Offering	04-18	MT
Genetic Technologies Limited Establishes Precision Oncology Division	04-17	CI
Genetic Technologies Launches GeneType Precision Oncology Brand, Diagnostic Tests	04-17	MT
Genetic Technologies Limited Establishes Clinical Implementation Study with Breast Screen Centres Across New York, Miami and Houston	04-11	CI
Genetic Technologies to Conduct Breast Cancer Integration Study in US	04-11	MT
Genetic Technologies Secures Short-Term Loan from Radium Capital	03-26	MT
Genetic Technologies Limited Announces the Appointment of Kathryn Andrews as Chief Financial Officer	03-25	CI

Chart Genetic Technologies Limited

Duration

Period

More charts

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company operates through three segments: EasyDNA, AffinityDNA, and GeneType / Corporate. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and mor

Sector

Healthcare Facilities & Services

Calendar

28/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
GENETIC TECHNOLOGIES LIMITED	-40.00%	6.62M
HCA HEALTHCARE, INC.	+18.69%	84.15B
CVS HEALTH CORPORATION	-25.20%	74.14B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.92%	26.77B
LABCORP HOLDINGS INC.	-10.46%	17.15B
FRESENIUS SE & CO. KGAA	+0.04%	16.83B
QUEST DIAGNOSTICS INCORPORATED	-0.73%	15.21B
NATERA, INC.	+72.88%	13.3B
TENET HEALTHCARE CORPORATION	+76.04%	12.99B
PURE HEALTH HOLDING	-25.79%	12.79B